Search Results - "Naylor, David E."

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus by Naylor, David E, Liu, Hantao, Niquet, Jerome, Wasterlain, Claude G

    Published in Neurobiology of disease (01-06-2013)
    “…Abstract After 1 h of lithium-pilocarpine status epilepticus (SE), immunocytochemical labeling of NMDA receptor NR1 subunits reveals relocation of subunits…”
    Get full text
    Journal Article
  2. 2

    In the fast lane: Receptor trafficking during status epilepticus by Naylor, David E.

    Published in Epilepsia open (01-05-2023)
    “…Status epilepticus (SE) remains a significant cause of morbidity and mortality and often is refractory to standard first‐line treatments. A rapid loss of…”
    Get full text
    Journal Article
  3. 3

    Introduction to the special issue on status epilepticus: neuronal injury, plasticity, and therapies; Celebrating the legacy of Dr. Claude G. Wasterlain by Engel Jr, Jerome, Moshé, Solomon L., Nehlig, Astrid, Fujikawa, Denson G., Sankar, Raman, Naylor, David E., Mazarati, Andrey M., Wasterlain, Claude G.

    Published in Epilepsia open (01-05-2023)
    “…The main content is largely based on presentations given at the symposium Pathophysiology and Treatment of Status Epilepticus, held in honor of Claude at the…”
    Get full text
    Journal Article
  4. 4

    Trafficking of GABAA Receptors, Loss of Inhibition, and a Mechanism for Pharmacoresistance in Status Epilepticus by Naylor, David E, Liu, Hantao, Wasterlain, Claude G

    Published in The Journal of neuroscience (24-08-2005)
    “…During status epilepticus (SE), GABAergic mechanisms fail and seizures become self-sustaining and pharmacoresistant. During lithiumpilocarpine-induced SE, our…”
    Get full text
    Journal Article
  5. 5

    Glutamate and GABA in the balance: Convergent pathways sustain seizures during status epilepticus by Naylor, David E.

    Published in Epilepsia (Copenhagen) (01-07-2010)
    “…Summary Seizures rapidly become self‐sustaining and pharmacoresistant to benzodiazepines during status epilepticus (SE). A decrease in the number of…”
    Get full text
    Journal Article Conference Proceeding
  6. 6

    Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus by Naylor, David E, Liu, Hantao, Wasterlain, Claude G

    Published in The Journal of neuroscience (24-08-2005)
    “…During status epilepticus (SE), GABAergic mechanisms fail and seizures become self-sustaining and pharmacoresistant. During lithiumpilocarpine-induced SE, our…”
    Get full text
    Journal Article
  7. 7

    Trafficking of NMDA receptors during status epilepticus: Therapeutic implications by Wasterlain, Claude G., Naylor, David E., Liu, Hantao, Niquet, Jerome, Baldwin, Roger

    Published in Epilepsia (Copenhagen) (01-09-2013)
    “…Summary We used two models of status epilepticus (SE) to study trafficking of N‐methyl‐d‐aspartate (NMDA) receptors. SE is associated with increased surface…”
    Get full text
    Journal Article
  8. 8

    Treating acute seizures with benzodiazepines: does seizure duration matter? by Naylor, David E.

    Published in Epileptic disorders (01-10-2014)
    “…Several clinical trials have shown improved seizure control and outcome by early initiation of treatment with benzodiazepines, before arrival in the emergency…”
    Get full text
    Journal Article
  9. 9

    Rational polytherapy in the treatment of acute seizures and status epilepticus by Wasterlain, Claude G., Baldwin, Roger, Naylor, David E., Thompson, Kerry W., Suchomelova, Lucie, Niquet, Jerome

    Published in Epilepsia (Copenhagen) (01-10-2011)
    “…Summary We used a model of severe cholinergic status epilepticus (SE) to study polytherapy aimed at reversing the effects of seizure‐induced loss of synaptic…”
    Get full text
    Journal Article Conference Proceeding
  10. 10

    Safety of laronidase delivered into the spinal canal for treatment of cervical stenosis in mucopolysaccharidosis I by Dickson, Patricia I., Kaitila, Ilkka, Harmatz, Paul, Mlikotic, Anton, Chen, Agnes H., Victoroff, Alla, Passage, Merry B., Madden, Jacqueline, Le, Steven Q., Naylor, David E.

    Published in Molecular genetics and metabolism (01-09-2015)
    “…Enzyme replacement therapy with laronidase (recombinant human alpha-l-iduronidase) is successfully used to treat patients with mucopolysaccharidosis type I…”
    Get full text
    Journal Article
  11. 11
  12. 12

    GABA Synapses and the Rapid Loss of Inhibition to Dentate Gyrus Granule Cells after Brief Perforant‐Path Stimulation by Naylor, David E., Wasterlain, Claude G.

    Published in Epilepsia (Copenhagen) (01-07-2005)
    “…Purpose: To study the pharmacologic and synaptic basis for the early loss of paired‐pulse inhibition that occurs in the perforant‐path stimulation model of…”
    Get full text
    Journal Article Conference Proceeding
  13. 13

    Trafficking of GABA sub(A) Receptors, Loss of Inhibition, and a Mechanism for Pharmacoresistance in Status Epilepticus by Naylor, David E, Liu, Hantao, Wasterlain, Claude G

    Published in The Journal of neuroscience (01-08-2005)
    “…During status epilepticus (SE), GABAergic mechanisms fail and seizures become self-sustaining and pharmacoresistant. During lithiumpilocarpine-induced SE, our…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Computer enhancement of scalp-sphenoidal ictal EEG in patients with complex partial seizures by Naylor, D E, Lieb, J P, Risinger, M

    “…Color topographic maps of scalp/sphenoidal ictal EEG records were computer-generated in 5 patients with medically refractory complex partial seizures of…”
    Get more information
    Journal Article